All Stories

  1. Correction: Wanderer et al. The Role of Losartan as a Potential Neuroregenerative Pharmacological Agent after Aneurysmal Subarachnoid Haemorrhage. Int. J. Mol. Sci. 2020, 21, 6496
  2. Frailty in Traumatic Brain Injury—The Significance of Temporal Muscle Thickness
  3. Invasive Diagnostic and Therapeutic Management of Cerebral VasoSpasm after Aneurysmal Subarachnoid Hemorrhage (IMCVS)—A Phase 2 Randomized Controlled Trial
  4. Early Epilepsy Surgery in Benign Cerebral Tumors: Avoid Your ‘Low-Grade’ Becoming a ‘Long-Term’ Epilepsy-Associated Tumor
  5. Experimental Induction of Intracranial Aneurysms in Rats: A New Model Utilizing a Genetic Modification within the EDNRA Gene
  6. Cerebrospinal Fluid System Infection in Children with Cancer: A Retrospective Analysis over 14 Years in a Major European Pediatric Cancer Center
  7. Detecting Sepsis in Patients with Severe Subarachnoid Hemorrhage during Critical Care
  8. Therapeutic Anticoagulation Impacts MR Morphologic Recurrence Patterns in Glioblastoma—A Matched-Pair Analysis
  9. Efficacy of Intraoperative Blood Salvage in Cerebral Aneurysm Surgery
  10. Short- and Long-Term Effects of Rehabilitation after Perimesencephalic Subarachnoid Hemorrhage
  11. Evaluation of a Novel Three-Dimensional Robotic Digital Microscope (Aeos) in Neurosurgery
  12. A Paravermal Trans-Cerebellar Approach to the Posterior Fossa Tumor Causes Hypertrophic Olivary Degeneration by Dentate Nucleus Injury
  13. Early versus Delayed Surgery for Spinal Epidural Abscess : Clinical Outcome and Health-Related Quality of Life
  14. Pre- and Post-Surgical Dysphagia in Adults with Tumors of the Posterior Fossa: A Prospective Blinded Study
  15. The Role of Losartan as a Potential Neuroregenerative Pharmacological Agent after Aneurysmal Subarachnoid Haemorrhage
  16. Procedures performed during neurosurgery residency in Europe
  17. Reactive Thrombocytosis in Non-aneurysmal Subarachnoid Hemorrhage
  18. Pulmonary embolism in neurocritical care-introduction of a novel grading system for risk stratification: the Frankfurt AMBOS score
  19. Global Perspectives on Task Shifting and Task Sharing in Neurosurgery
  20. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage
  21. National Institutes of Health Stroke Scale (NIHSS) on admission predicts acute symptomatic seizure risk in ischemic stroke: a population-based study involving 135,117 cases
  22. Acute symptomatic seizures in intracerebral and subarachnoid hemorrhage: A population study of 19,331 patients
  23. External validation and modification of the Oslo grading system for prediction of postoperative recurrence of chronic subdural hematoma
  24. A novel grading system for the prediction of the need for cerebrospinal fluid drainage following posterior fossa tumor surgery
  25. Delayed Occurrence of Hypertrophic Olivary Degeneration after Therapy of Posterior Fossa Tumors: A Single Institution Retrospective Analysis
  26. Treatment of refractory and superrefractory status epilepticus with topiramate: A cohort study of 106 patients and a review of the literature
  27. Does aneurysm side influence the infarction side and patients´ outcome after subarachnoid hemorrhage?
  28. Vitamin K Antagonist (Phenprocoumon) and Subarachnoid Hemorrhage: A Single-Center, Matched-Pair Analysis
  29. Thrombosis of the straight sinus and microbleedings due to deep seated arteriovenous fistula – Hemodynamic changes, cognitive impairment and improvement after microsurgery. A technical report
  30. Susceptibility‐weighted imaging ( SWI ) or T2* contrasts should remain standard in the neuroimaging of epilepsy
  31. Management of hydrocephalus after resection of posterior fossa lesions in pediatric and adult patients—predictors for development of hydrocephalus
  32. The Extent of Neurologic Improvement and Social Life in Young Patients with Ruptured and Unruptured Brain AVM: A Long-Term Follow-Up
  33. Seizure and status epilepticus in chronic subdural hematoma
  34. Differences in bleeding patterns and outcome after intracerebral hemorrhage due to vascular malformations
  35. First clinical experience with the new noninvasive transfontanelle ICP monitoring device in management of children with premature IVH
  36. Cerebral Vasospasm Due to Arteriovenous Malformation-Associated Hemorrhage: Impact of Bleeding Source and Pattern
  37. Clinical Relevance of Seizure in Pediatric Patients with Isolated Acute Subdural Hematoma without Parenchymal Brain Injury
  38. Electrode placement accuracy in robot-assisted epilepsy surgery: A comparison of different referencing techniques including frame-based CT versus facial laser scan based on CT or MRI
  39. Infective endocarditis in patients with pyogenic spondylodiscitis: implications for diagnosis and therapy
  40. Comparison of carotid and basilar bifurcation aneurysms versus non-T-angled bifurcations: the geometry is associated with the outcome
  41. The clinical relevance of ABO blood type in 100 patients with acute subdural hematoma
  42. Vasospasm of the basilar artery following spontaneous SAH—clinical observations and implications for vascular research
  43. Risk factors for dropping Out of NeurosurgIcal resideNcy programs - The RONIN Survey
  44. Excellent accuracy of ABC/2 volume formula compared to computer-assisted volumetric analysis of subdural hematomas
  45. Pain medication at ictus of subarachnoid hemorrhage—the influence of one-time acetylsalicylic acid usage on bleeding pattern, treatment course, and outcome: a matched pair analysis
  46. Rapid ventricular pacing for clip reconstruction of complex unruptured intracranial aneurysms: results of an interdisciplinary prospective trial
  47. Editorial. To pace or not to pace: that is the question
  48. Point-of-Care-Gerinnungsdiagnostik in der Neurochirurgie
  49. Levosimendan Reduces Prostaglandin F2a-dependent Vasoconstriction in Physiological Vessels and After Experimentally Induced Subarachnoid Hemorrhage
  50. Continuous Acetylsalicylic Acid Treatment Does Not Influence Bleeding Pattern or Outcome of Aneurysmal Subarachnoid Hemorrhage: A Matched-Pair Analysis
  51. Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk?
  52. Influence of ABO blood type on the outcome after non-aneurysmal subarachnoid hemorrhage
  53. A benchmark approach to hemorrhage risk management of cavernous malformations
  54. Outcome after Hunt and Hess Grade V subarachnoid hemorrhage: a comparison of pre-coiling era (1980–1995) versus post-ISAT era (2005–2014)
  55. Correction to: Vasomodulatory effects of the angiotensin II type 1 receptor antagonist losartan on experimentally induced cerebral vasospasm after subarachnoid haemorrhage
  56. Vasomodulatory effects of the angiotensin II type 1 receptor antagonist losartan on experimentally induced cerebral vasospasm after subarachnoid haemorrhage
  57. Significant increase in acute subdural hematoma in octo- and nonagenarians: surgical treatment, functional outcome, and predictors in this patient cohort
  58. Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome
  59. International multicentre validation of the arteriovenous malformation-related intracerebral haemorrhage (AVICH) score
  60. Subarachnoid Hemorrhage in Advanced Age: Comparison of Patients Aged 70–79 Years and 80 Years and Older
  61. Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage
  62. CVS-dependent and CVS-independent Cerebral Infarctions Predict Outcome after Non-Aneurysmal Subarachnoid Hemorrhage: a Single-Center Series with 250 Patients
  63. Outcome After Subarachnoid Hemorrhage from Blood Blister–Like Aneurysm Rupture Depends on Age and Aneurysm Morphology
  64. Positive influence of partial resection on overall survival of patients with overlapping glioblastomas
  65. MRI-detection rate and incidence of lumbar bleeding sources in 190 patients with non-aneurysmal SAH
  66. Early diffusion-weighted MRI lesions after treatment of unruptured intracranial aneurysms: a prospective study
  67. Optimization of the Surgical Approach in AVMs Using MRI and 4D DSA Fusion Technique
  68. Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor
  69. Effect of heparin on secondary brain injury in patients with subarachnoid hemorrhage: an additional ‘H’ therapy in vasospasm treatment
  70. Increased risk of delayed cerebral ischemia in subarachnoid hemorrhage patients with additional intracerebral hematoma
  71. Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma
  72. A systematic review of epileptic seizures in adults with subdural haematomas
  73. Epileptic seizures in patients following surgical treatment of acute subdural hematoma – incidence, risk factors, patient outcome and development of a new scoring system for prophylactic antiepileptic treatment (GATE 24-score)
  74. The Role of ABO Blood Group in Cerebral Vasospasm, Associated Intracranial Hemorrhage, and Delayed Cerebral Ischemia in 470 Patients with Subarachnoid Hemorrhage
  75. Outcome and prognostic factors after delayed second subarachnoid haemorrhage
  76. Outcome, prognostic factors and follow up results after subarachnoid hemorrhage from pericallosal artery aneurysms
  77. Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?
  78. General anesthesia versus local anesthesia in stereotactic biopsies of brain lesions – a prospective randomized study
  79. Aneurysm Location as a Prognostic Outcome Factor After Subarachnoid Hemorrhage From Internal Carotid Artery Aneurysms and Potential Impact for Further Experimental Subarachnoid Hemorrhage Models
  80. The Impact of Tracheostomy Timing on Clinical Outcome and Adverse Events in Poor-Grade Subarachnoid Hemorrhage
  81. Increasing numbers of nonaneurysmal subarachnoid hemorrhage in the last 15 years: antithrombotic medication as reason and prognostic factor?
  82. Outcome of Patients with Long-Lasting Cerebral Vasospasm After Subarachnoid Hemorrhage: Is Prolonged Treatment for Cerebral Vasospasm Worthwhile? A Matched-Pair Analysis
  83. Non-aneurysmal non-perimesencephalic subarachnoid hemorrhage: effect of rehabilitation at short-term and in a prospective study of long-term follow-up
  84. Cerebral vasospasm and delayed cerebral infarctions in 225 patients with non-aneurysmal subarachnoid hemorrhage: the underestimated risk of Fisher 3 blood distribution
  85. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma
  86. Cerebral foreign body granuloma in brain triggering generalized seizures without obvious craniocerebral injury: A case report and review of the literature
  87. Ventriculostomy-Related Hemorrhage After Treatment of Acutely Ruptured Aneurysms: The Influence of Anticoagulation and Antiplatelet Treatment
  88. Evaluation of the perforators of the anterior communicating artery (AComA) using routine cerebral 3D rotational angiography
  89. The Impact of Tracheostomy Timing on Clinical Outcome and Adverse Events in Poor-Grade Subarachnoid Hemorrhage*
  90. Non-aneurysmal subarachnoid hemorrhage, large prospective study of long-term outcome
  91. Endovascular and Surgical Treatment of Internal Carotid Bifurcation Aneurysms
  92. Frequency, risk of hemorrhage and treatment considerations for cerebral arteriovenous malformations with associated aneurysms
  93. Clinical outcome and prognostic factors of patients with angiogram-negative and non-perimesencephalic subarachnoid hemorrhage: benign prognosis like perimesencephalic SAH or same risk as aneurysmal SAH?
  94. Non-aneurysmal non-traumatic subarachnoid hemorrhage: patient characteristics, clinical outcome and prognostic factors based on a single-center experience in 125 patients
  95. Natural History of Small Unruptured Anterior Circulation Aneurysms: A Prospective Cohort Study
  96. Erythropoietin prevents delayed hemodynamic dysfunction after subarachnoid hemorrhage in a randomized controlled experimental setting
  97. Crosstalk Between the Angiotensin and Endothelin-System in the Cerebrovasculature
  98. The Impact of the Body Mass Index on Outcome After Subarachnoid Hemorrhage
  99. Aneurysm-related subarachnoid hemorrhage and acute subdural hematoma: single-center series and systematic review
  100. Functional Effects of Levosimendan in Rat Basilar Arteries In Vitro
  101. Functional Effects of Levosimendan in Rat Basilar Arteries In Vitro
  102. Endothelin Related Pathophysiology in Cerebral Vasospasm: What Happens to the Cerebral Vessels?
  103. Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function
  104. CHARACTERIZATION OF THE ENDOTHELIN-B RECEPTOR EXPRESSION AND VASOMOTOR FUNCTION DURING EXPERIMENTAL CEREBRAL VASOSPASM
  105. Time Course in the Development of Cerebral Vasospasm after Experimental Subarachnoid Hemorrhage: Clinical and Neuroradiological Assessment of the Rat Double Hemorrhage Model
  106. Determination of the time course of experimental cerebral vasospasm in the rat double subarachnoid hemorrhage model by neurological score, selective vertebro-basilar angiography, and perfusion weighted magnet resonance imaging